Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1308-2019

Drug recall · June 5, 2019

Bevacizumab 2.5 mg/0.1 mL recall

Why: Lack of assurance of sterility

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27

Lots / codes

Lot #: 138-20191202@64, Exp 05/13/19

Quantity
730 syringes
Company
Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
Distribution
U.S.A. nationwide
Initiated
May 3, 2019 · Voluntary: Firm initiated
Classified
May 29, 2019
Reported
June 5, 2019
Ended
February 25, 2020
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.